Y-mAbs Therapeutics Inc
(NASDAQ:YMAB)
$6.21
0.24[4.02%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$6.21
0[0.00%]
After-Hours
Open6.420Close6.210
Vol / Avg.230.550K / 172.209KMkt Cap270.890M
Day Range6.200 - 6.79052 Wk Range2.700 - 10.950

Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert
11/13/2023YMAB
Y-mAbs Therapeutics
FY2023$80.00M$85.00M$83.76MGet Alert
08/10/2023YMAB
Y-mAbs Therapeutics
FY2023$80.00M$85.00M$82.79MGet Alert
11/07/2022YMAB
Y-mAbs Therapeutics
FY2022$45.00M$50.00M$51.75MGet Alert
08/08/2022YMAB
Y-mAbs Therapeutics
FY2022$45.00M$50.00M$60.18MGet Alert
04/27/2022YMAB
Y-mAbs Therapeutics
Q12022$10.50M$10.50M$10.99MGet Alert
04/27/2022YMAB
Y-mAbs Therapeutics
FY2022$45.00M$50.00M$67.81MGet Alert
Q

What is the most recent guidance for Y-mAbs Therapeutics (YMAB)?

A

There have been no specific sales or earnings guidance reported for Y-mAbs Therapeutics in recent months.

Browse guidance and forecast on all stocks.